Skip to content
AtmosR logo

AtmosR Alternatives & Competitors

12 companies similar to AtmosR — Pioneering treatments to restore autonomous breathing and safety for those with...

Companies similar to AtmosR

Travecta Therapeutics logo — alternative to AtmosR

Travecta Therapeutics

Pioneering advancements in central nervous system treatments with innovative solutions for...

Cerebral Therapeutics, Inc. logo — alternative to AtmosR

Cerebral Therapeutics, Inc.

A clinical stage pharmaceutical company developing innovative treatments for neurological...

Umecrine Cognition AB logo — alternative to AtmosR

Umecrine Cognition AB

A novel and safe approach for treating cognitive disorders

Emalex Biosciences logo — alternative to AtmosR

Emalex Biosciences

Improving people's lives impacted by central nervous system disorders through meaningful s...

Rival Readout

Competing with AtmosR? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout
CNS Therapeutics logo — alternative to AtmosR

CNS Therapeutics

Delivering advanced neurological and pain treatments with precision and expertise

Disarm Therapeutics logo — alternative to AtmosR

Disarm Therapeutics

Creating advanced therapeutics to combat axonal degeneration and treat neurological diseas...

Praxis Precision Medicines, Inc. logo — alternative to AtmosR

Praxis Precision Medicines, Inc.

The era of genetic neuroscience has arrived

Apic Bio logo — alternative to AtmosR

Apic Bio

Pioneering gene therapies for rare neurological and liver diseases, targeting Alpha-1 Anti...

Hoba Therapeutics logo — alternative to AtmosR

Hoba Therapeutics

Developing Restorative Treatments for Chronic Neuropathic Pain and Hearing Loss

Acadia Pharmaceuticals logo — alternative to AtmosR

Acadia Pharmaceuticals

Acadia is trailblazing breakthroughs in neuroscience to elevate life.

XWPharma logo — alternative to AtmosR

XWPharma

Neuroscience biotech developing novel therapeutics for sleep, neuropsych, and other unders...

Chance Pharmaceuticals 畅溪制药 logo — alternative to AtmosR

Chance Pharmaceuticals 畅溪制药

A clinical-stage biotech company focusing on discovering, developing and commercializing i...

About AtmosR

AtmosR is a biotech startup that focuses on developing pioneering treatments for rare and severe disorders of the central nervous system. Their flagship drug, ATS-003, aims to restore autonomous breathing in CCHS patients, thus eliminating a critical risk and enabling greater independence. Founded in 2019, the company...

Business keywords

Biotech Company, Central Nervous System Disorders, ATS-003, Rare Disorders, Autonomous Breathing, CCHS Patients, Innovative Treatments, Aix En Provence, Paris, Drug Development, Rare Disease, Neurological Disorders

Frequently Asked Questions

Companies similar to AtmosR include Travecta Therapeutics, Cerebral Therapeutics, Inc., Umecrine Cognition AB, Emalex Biosciences, CNS Therapeutics. They work in Biotechnology and Health Care and share AtmosR's focus on neurological disorders, drug development and central nervous system disorders.
Bounce Watch lists 12 companies that share AtmosR's industries and are closest to it in business tags, services, target customers, business model and size.
AtmosR is a biotech startup that focuses on developing pioneering treatments for rare and severe disorders of the central nervous system. Their flagship drug, ATS-003, aims to restore autonomous breathing in CCHS patients, thus eliminating a critical risk and enabling greater independence. Founded in 2019, the company...

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around AtmosR: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Compiled from the BounceWatch company index. We last looked at AtmosR on 26 Jul 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout